Vivos Primary Function: Sistema sa Operasyon sa Mata by Olcayto Guelec and David Geuder

Vivos Primary Function: Sistema sa Operasyon sa Mata by Olcayto Guelec and David Geuder is a highly esteemed winner of the very prestigious 2026 A' Design Award nga Bulawan in Disenyo sa Aparatong Medikal ug Kagamitan Medikal Competition Category.

BulawanProduktong Medikal· 2026

Vivos Primary Function: Sistema sa Operasyon sa Mata

by Olcayto Guelec and David Geuder

Client: Geuder AG

A' Design Award nga Bulawan Winner in Produktong Medikal Category

53,358
Verified Award Winner
Verify Award Status for #182492

View at A' Design Award Press Release Award Badge

Colors

The Design

About Vivos Primary Function: Sistema sa Operasyon sa Mata

Book Text: Gibag-o sa Vivos ang gimbuhaton sa operasyon isip usa ka plataporma nga mouswag uban sa klinikal nga ambisyon. Tulo ka konpigurasyon, ang Core, Nova, ug Nova+, nagpalapad sa katakos nga dili kinahanglan pulihan ang sistema, ang bugtong matang sa upgrade nga arkitektura sa operasyon sa mata. Ang usa ka interface, napamatud-an nga adunay 91.7 porsyento nga katagbawan sa unang paggamit nga walay una nga pagbansay, nagpakita sa usa ka disenyo nga gitukod palibot sa siruhano imbis sa proseso. Ang mga suga nga koneksyon sa instrumento, pino nga mga materyales ug pinugngan nga detalye naghatag sa aparato og kalma ug masaligon nga presensya, gawasnon sa biswal nga kasaba nga kasagaran sa kategoriya.

The Recognition

About the A' Design Award nga Bulawan

Vivos Primary Function: Sistema sa Operasyon sa Mata usa ka mananaog sa A' Design Award nga Bulawan, usa ka hilabihan ka prestihiyoso nga pag-ila nga gihatag sa unang-klase, katingalahan, ug bantogan nga mga disenyo. Ang mga mananaog sa Bulawan labihan ka bag-o, daghan og panan-aw, ug nagsidlak nga mga paglalang nga nagpakita sa henyo, kinaadman, ug kahanas sa ilang mga tigdesinyo. Gilauman nga ang Vivos Primary Function: Sistema sa Operasyon sa Mata mahimong labing gidayeg, nagtakda og uso, ug monumental nga imbento nga naghatag og bili nga wala pa makita. Kini nga disenyo nga nakadaog og A' Design Award nga Bulawan usa ka makapahingangha ug gitahod nga proyekto nga labihan ka mapuslanon ug nagpalapad sa mga utlanan sa arte, siyensya, disenyo, ug teknolohiya. Vivos Primary Function: Sistema sa Operasyon sa Mata nagmugna og kusog nga mga pagbati sa kaibog, nagpukaw og kahinam, nagdasig sa pagkamamugnaon, ug nagbihag kanato.

Behind the Design

Press Kit

Credits, team members and technical details provided by the designer.

Unique Properties: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Dimensions & Packaging: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Tags: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Production Technology: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Design Challenge: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Research: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspiration: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Project Duration: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Operation Flow: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Team Members: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Image Credits: Photography Geuder AG, 2026